Patents by Inventor Constance Auvynet

Constance Auvynet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIMICROBIAL PEPTIDES AND USES THEREOF
    Publication number: 20230192772
    Abstract: Peptides endowed with an anti-inflammatory, anti-angiogenic and/or antimicrobial activity, a medicament or a pharmaceutical composition including such peptides, and the use thereof in the prevention or treatment of inflammatory diseases, and more particularly inflammatory diseases due to or associated with microbial infections, or in the prevention or treatment of angiogenesis-related diseases.
    Type: Application
    Filed: December 22, 2017
    Publication date: June 22, 2023
    Applicants: SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITÉ PARIS-SUD 11, UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO
    Inventors: Claire LACOMBE, Constance AUVYNET, Yvonne ROSENSTEIN, Emmanuelle SACHON
  • CCR2 antagonist peptides
    Patent number: 10253087
    Abstract: The invention relates to a peptide useful as a CCR2 non-competitive antagonist peptide.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: April 9, 2019
    Assignee: Sorbonne University
    Inventors: Christophe Combadiere, Florian Sennlaub, Constance Auvynet, Sylvian Chemtob, Christiane Quiniou
  • CCR2 ANTAGONIST PEPTIDES
    Publication number: 20180251523
    Abstract: The invention relates to a peptide comprising the following amino acid sequence useful as a CCR2 non competitive antagonist peptide.
    Type: Application
    Filed: May 1, 2018
    Publication date: September 6, 2018
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE (Paris 6)
    Inventors: Christophe Combadiere, Florian Sennlaub, Constance Auvynet, Sylvian Chemtob, Christiane Quiniou
  • CCR2 ANTAGONIST PEPTIDES
    Publication number: 20170051040
    Abstract: The invention relates to a peptide comprising the following amino acid sequence Thr-Phe-Leu-Lys or Thr-Phe-Leu-Lys-Cys, useful as a CCR2 non competitive antagonist peptide.
    Type: Application
    Filed: September 2, 2016
    Publication date: February 23, 2017
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE (Paris 6)
    Inventors: Christophe Combadiere, Florian Sennlaub, Constance Auvynet, Sylvain Chemtob, Christiane Quiniou
  • CCR2 antagonist peptides
    Patent number: 9434766
    Abstract: The invention relates to a peptide comprising the following amino acid sequence Thr-Phe-Leu-Lys (SEQ ID NO: 17) or Thr-Phe-Leu-Lys-Cys (SEQ ID NO: 1), useful as a CCR2 non-competitive antagonist peptide.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: September 6, 2016
    Assignee: Universite Pierre Et Marie Curie (Paris 6)
    Inventors: Christophe Combadiere, Florian Sennlaub, Constance Auvynet, Sylvian Chemtob, Christiane Quiniou
  • CCR2 ANTAGONIST PEPTIDES
    Publication number: 20150011477
    Abstract: The invention relates to a peptide comprising the following amino acid sequence Thr-Phe-Leu-Lys or Thr-Phe-Leu-Lys-Cys, useful as a CCR2 non competitive antagonist peptide.
    Type: Application
    Filed: June 26, 2012
    Publication date: January 8, 2015
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE
    Inventors: Christophe Combadiere, Florian Sennlaub, Constance Auvynet, Sylvain Chemtob, Christiane Quiniou